RPG Life Sciences informs about outcome of board meeting

15 Dec 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III of the Listing Regulations, RPG Life Sciences has informed that the Board of Directors of the Company, at its meeting held today, Monday, December 15, 2025, considered and unanimously approved the following: 1. Appointment of Amol Lone as the Chief Financial Officer and Key Managerial Personnel (KMP) of the Company effective from December 15, 2025, based on the recommendation of the Nomination and Remuneration Committee of the Company. 2. Incorporation of a new wholly owned subsidiary (‘WOS’) of the Company, in the name and style ‘RPG Active Pharma’ or such other name, as may be approved by the Ministry of Corporate Affairs, to be engaged, in the business of manufacture and marketing of active pharmaceutical ingredients (‘API’) and related pharmaceutical products. 3. Transfer of the API business of the Company to the WOS (upon its incorporation), as a going concern, pursuant to a business transfer agreement, and subject to receipt of applicable statutory and regulatory approvals. 4. Investment of an amount of up to Rs.105 crore in the WOS, in one or more tranches, for the purpose of capitalization, business operations and/or other related requirements. Necessary disclosures as required under the Listing Regulations read with applicable SEBI circulars shall be made as and when further investment is made in the WOS. The detailed disclosures as required under Regulation 30 read with Schedule III of the Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (‘SEBI Master Circular’), in respect of aforesaid matters are enclosed as Annexures I, II and III, respectively. The meeting commenced at 02:00 pm and concluded at 3.10 pm.

The above information is a part of company’s filings submitted to BSE.

RPG Life Sciences Share Price

2372.25 64.15 (2.78%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×